BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Perlegen Sciences, Inc. 

2021 Stierlin Road

Mountain View  California  94043  U.S.A.
Phone: 650-625-4500 Fax: 650-625-4580


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Genomics





 Company News
Perlegen Sciences, Inc. Introduces BREVAGen Breast Cancer Risk Stratification Test 9/24/2009 7:15:39 AM
Perlegen Sciences, Inc. Introduces BREVAGen(TM) Breast Cancer Risk Stratification Test 9/23/2009 11:34:25 AM
Perlegen Sciences, Inc. Receives CLIA License 6/5/2009 9:34:46 AM
Perlegen Sciences, Inc. Builds Commercial Group to Support Upcoming MammaPLUS(TM) Launch 4/28/2009 11:51:38 AM
Perlegen Sciences, Inc. Out-Licenses Genetic Diagnostics Intellectual Property to Celera Corporation (CRA) 4/23/2009 10:17:42 AM
Perlegen Sciences, Inc. Launches New Approach to Detect Rare Genetic Variants 9/16/2008 2:49:38 PM
Perlegen Sciences, Inc. Out-Licenses Intellectual Property for Genetic Diagnostics 7/15/2008 6:28:10 AM
Perlegen Sciences, Inc. Gains Exclusive Access to Data on Four Million Patients to Enable Personalized Medicine 3/18/2008 10:12:52 AM
Perlegen Sciences, Inc. and SC Liver Research Consortium to Collaborate on Interferon Response in Hepatitis C Patients 2/19/2008 8:36:56 AM
Perlegen Sciences, Inc. Fills out Leadership Team to Prepare for Multiple Personalized Medicine Programs 2/14/2008 8:33:04 AM
123456